Food and Drug Administration (FDA)
FDA Approves First COVID-19 Vaccine
As of August 23, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
Considerations for Selecting Respirators for Your Health Care Facility
This flowchart illustrates which Emergency Use Authorization (EUA) applies to specific respirator types and provides links to information on performance factors for each type to consider when selecting respirators for use in health care facilities in the United States.
7/2/2020: UPDATE - FDA warns consumers of risk of methanol contamination in certain hand sanitizers
FDA is warning consumers and health care providers that the agency has seen a sharp increase in hand sanitizer products that are labeled to contain ethanol (also known as ethyl alcohol) but that have tested positive for methanol contamination.
FDA advises consumers not use hand sanitizer products manufactured by Eskbiochem
FDA release advising "consumers not to use any hand sanitizer manufactured by Eskbiochem SA de CV in Mexico, due to the potential presence of methanol (wood alcohol), a substance that can be toxic when absorbed through the skin or ingested. FDA has identified the following products." (6/19/2020) Spanish version